Ronald W. Hart, Ph.D.

Dr. Hart is an internationally recognized scientist, scholar and expert in business acceleration strategies for emerging growth companies. He is the former Chief Scientist and Executive Director of the FDA’s National Center for Toxicology Research and was the first person in the history of the FDA to be named “distinguished scientist in residence.” In addition, he was an author of the Federal Technology Transfer Act of 1986 and a co-founder of the Korean Institute of Science and technology.

Dr. Hart has received over two dozen national and international awards and recognitions for his scientific contributions, including the Karl August Forester Preis from the German Academy of Science and Literature, the Bose Medal from the Bose Institute of India, and appointments as Distinguished Professor at a number of institutes, including Cairo University and Guangzhou University. Dr. Hart has served on the boards and advisory committees of the National Academy of Science, including as Chairman of the Committee on Indoor Air. In addition, he has served on the editorial boards of more than a dozen professional journals, has authored or co-authored over 600 scientific publications, and has served as editor for six scientific volumes.  Dr. Hart serves either as a director or as a strategic advisor to public and private companies, including:  Guided Therapeutics, Neogenix, St. Renatus, Apogee Power, Ice Energy, and SNTech.  Dr. Hart received his Ph.D. in physiology and biophysics from the University of Illinois in 1971.